| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0005 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.007 |